Jennison Associates LLC Apellis Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

  • $160 Billion
  • Q3 2024

A detailed history of Jennison Associates LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 1,821,115 shares of APLS stock, worth $60.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,821,115
Previous 3,591,416 49.29%
Holding current value
$60.5 Million
Previous $138 Million 61.88%
% of portfolio
0.03%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$28.84 - $41.15 $51.1 Million - $72.8 Million
-1,770,301 Reduced 49.29%
1,821,115 $52.5 Million
Q2 2024

Aug 05, 2024
BUY
$38.07 - $59.71 $13.4 Million - $21 Million
350,903 Added 10.83%
3,591,416 $138 Million
Q1 2024

May 02, 2024
SELL
$55.39 - $72.47 $1.96 Million - $2.57 Million
-35,409 Reduced 1.08%
3,240,513 $190 Million
Q4 2023

Feb 01, 2024
SELL
$37.14 - $64.82 $9.89 Million - $17.3 Million
-266,287 Reduced 7.52%
3,275,922 $196 Million
Q3 2023

Oct 31, 2023
BUY
$23.65 - $89.22 $37.2 Million - $140 Million
1,571,606 Added 79.75%
3,542,209 $135 Million
Q2 2023

Aug 03, 2023
SELL
$76.68 - $93.31 $49.2 Million - $59.9 Million
-642,164 Reduced 24.58%
1,970,603 $180 Million
Q1 2023

Apr 26, 2023
BUY
$46.59 - $66.96 $4.54 Million - $6.53 Million
97,450 Added 3.87%
2,612,767 $172 Million
Q4 2022

Feb 09, 2023
SELL
$43.24 - $61.04 $838,639 - $1.18 Million
-19,395 Reduced 0.77%
2,515,317 $130 Million
Q3 2022

Nov 01, 2022
BUY
$44.76 - $69.66 $10.6 Million - $16.5 Million
236,365 Added 10.28%
2,534,712 $173 Million
Q2 2022

Aug 02, 2022
SELL
$35.07 - $59.21 $14.2 Million - $24 Million
-406,043 Reduced 15.01%
2,298,347 $104 Million
Q1 2022

May 11, 2022
BUY
$35.46 - $54.12 $29.9 Million - $45.6 Million
842,233 Added 45.23%
2,704,390 $137 Million
Q4 2021

Feb 08, 2022
SELL
$30.74 - $49.16 $6.66 Million - $10.7 Million
-216,688 Reduced 10.42%
1,862,157 $88 Million
Q3 2021

Nov 09, 2021
SELL
$31.4 - $69.84 $11.6 Million - $25.9 Million
-370,679 Reduced 15.13%
2,078,845 $68.5 Million
Q2 2021

Aug 12, 2021
SELL
$40.9 - $64.9 $10.7 Million - $17 Million
-261,353 Reduced 9.64%
2,449,524 $155 Million
Q1 2021

May 11, 2021
SELL
$40.8 - $57.39 $2.51 Million - $3.53 Million
-61,543 Reduced 2.22%
2,710,877 $116 Million
Q4 2020

Feb 05, 2021
SELL
$30.79 - $57.2 $2.01 Million - $3.74 Million
-65,366 Reduced 2.3%
2,772,420 $159 Million
Q3 2020

Nov 04, 2020
BUY
$25.89 - $33.65 $18.4 Million - $23.9 Million
710,708 Added 33.41%
2,837,786 $85.6 Million
Q2 2020

Aug 06, 2020
BUY
$24.8 - $38.49 $931,512 - $1.45 Million
37,561 Added 1.8%
2,127,078 $69.5 Million
Q1 2020

May 06, 2020
BUY
$17.91 - $44.33 $17.6 Million - $43.6 Million
984,486 Added 89.09%
2,089,517 $56 Million
Q4 2019

Feb 07, 2020
BUY
$22.1 - $30.8 $147,539 - $205,620
6,676 Added 0.61%
1,105,031 $33.8 Million
Q3 2019

Nov 08, 2019
BUY
$24.09 - $32.18 $4.22 Million - $5.64 Million
175,111 Added 18.97%
1,098,355 $26.5 Million
Q2 2019

Aug 06, 2019
BUY
$18.0 - $25.34 $6.05 Million - $8.51 Million
335,863 Added 57.18%
923,244 $0
Q1 2019

May 10, 2019
BUY
$12.81 - $19.82 $5,854 - $9,057
457 Added 0.08%
587,381 $11.5 Million
Q4 2018

Feb 06, 2019
BUY
$11.47 - $18.71 $138,385 - $225,736
12,065 Added 2.1%
586,924 $7.74 Million
Q3 2018

Nov 08, 2018
BUY
$16.57 - $21.03 $72,825 - $92,426
4,395 Added 0.77%
574,859 $10.2 Million
Q2 2018

Aug 02, 2018
BUY
$19.63 - $30.0 $3.76 Million - $5.74 Million
191,313 Added 50.46%
570,464 $12.6 Million
Q1 2018

Apr 20, 2018
SELL
$14.01 - $26.02 $3.19 Million - $5.93 Million
-227,774 Reduced 37.53%
379,151 $8.38 Million
Q4 2017

Jan 25, 2018
BUY
$12.71 - $21.7 $7.71 Million - $13.2 Million
606,925
606,925 $13.2 Million

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.65B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email